Reovirus receptors, cell entry, and proapoptotic signaling

Advances in Experimental Medicine and Biology

Volumn 790, Issue , 2013, Pages 42-71

  Danthi, Pranav ^a   Holm, Geoffrey H ^b   Stehle, Thilo ^c,d   Dermody, Terence S ^c  

^a INDIANA UNIVERSITY   (United States)

^b Center for Language and Brain   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CARBOHYDRATE; CATHEPSIN; CYSTEINE PROTEINASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; JUNCTIONAL ADHESION MOLECULE A; MEMBRANE PENETRATION PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SIALIC ACID; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

APOPTOSIS; ARTICLE; CONFORMATIONAL TRANSITION; CYTOPLASM; ENDOCYTOSIS; GENE EXPRESSION; HOST CELL; HUMAN; IN VIVO STUDY; INTERNALIZATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REOVIRUS; REOVIRUS INFECTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS PARTICLE;

ANIMALS; APOPTOSIS; ENDOCYTOSIS; HUMANS; N-ACETYLNEURAMINIC ACID; NF-KAPPA B; RECEPTORS, VIRUS; REOVIRIDAE; REOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VIRUS INTERNALIZATION;

EID: 84881421766     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7651-1_3     Document Type: Article

References (192)

1. Dermody TS, Parker JS, Sherry B. Orthoreoviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Sixth Edition. Philadelphia: Lippincott Williams & Wilkins, In press.
2. Virgin HW, Tyler KL, Dermody TS. Reovirus. In: Nathanson N, ed. Viral Pathogenesis. New York: Lippincott-Raven, 1997:669-699.
3. Duncan R, Horne D, Cashdollar LW et al. Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus. Virology 1990; 174:399-409.
4. Nibert ML, Dermody TS, Fields BN. Structure of the reovirus cell-attachment protein: A model for the domain organization of 1. J Virol 1990; 64:2976-2989.
5. Tyler KL, McPhee DA, Fields BN. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 1986; 233:770-774.
6. Weiner HL, Powers ML, Fields BN. Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin. J Infect Dis 1980; 141:609-616.
7. Weiner HL, Drayna D, Averill Jr DR et al. Molecular basis of reovirus virulence: Role of the S1 gene. Proc Natl Acad Sci USA 1977; 74:5744-5748.
8. Morrison LA, Sidman RL, Fields BN. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci USA 1991; 88:3852-3856.
9. Tardieu M, Powers ML, Weiner HL. Age-dependent susceptibility to reovirus type 3 encephalitis: Role of viral and host factors. Ann Neurol 1983; 13:602-607.
10. Dichter MA, Weiner HL. Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism. Ann Neurol 1984; 16:603-610.
11. Weiner HL, Ault KA, Fields BN. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol 1980; 124:2143-2148.
12. Lee PW, Hayes EC, Joklik WK. Protein 1 is the reovirus cell attachment protein. Virology 1981; 108:156-163.
13. Furlong DB, Nibert ML, Fields BN. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol 1988; 62:246-256.
14. Fraser RDB, Furlong DB, Trus BL et al. Molecular structure of the cell-attachment protein of reovirus: Correlation of computer-processed electron micrographs with sequence-based predictions. J Virol 1990; 64:2990-3000.
15. Gentsch JR, Pacitti AF. Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells. J Virol 1985; 56:356-364.
16. Paul RW, Choi AH, Lee PWK. The -anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus. Virology 1989; 172:382-385.
17. Dermody TS, Nibert ML, Bassel-Duby R et al. Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol 1990; 64:4842-4850.
18. Chappell JD, Gunn VL, Wetzel JD et al. Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol 1997; 71:1834-1841.
19. Chappell JD, Duong JL, Wright BW et al. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 2000; 74:8472-8479.
20. Barton ES, Forrest JC, Connolly JL et al. Junction adhesion molecule is a receptor for reovirus. Cell 2001; 104:441-451.
21. Martin-Padura I, Lostaglio S, Schneemann M et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998; 142:117-127.
22. Williams LA, Martin-Padura I, Dejana E et al. Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol 1999; 36:1175-1188.
23. Liu Y, Nusrat A, Schnell FJ et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113:2363-2374.
24. Dryden KA, Wang G, Yeager M et al. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: Analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J Cell Biol 1993; 122:1023-1041.
25. Chappell JD, Prota A, Dermody TS et al. Crystal structure of reovirus attachment protein 1 reveals evolutionary relationship to adenovirus fiber. EMBO J 2002; 21:1-11.
26. Reiter DM, Frierson JM, Halvorson EE et al. Crystal structure of reovirus attachment protein 1 in complex with sialylated oligosaccharides. PLoS Pathog 2011; 7:e1002166.
27. van Raaij MJ, Mitraki A, Lavigne G et al. A triple γ-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein. Nature 1999; 401:935-938.
28. Guardado CP, Fox GC, Hermo Parrado XL et al. Structure of the carboxy-terminal receptor-binding domain of avian reovirus fibre sigmaC. J Mol Biol 2005; 354:137-149.
29. Prota AE, Campbell JA, Schelling P et al. Crystal structure of human junctional adhesion molecule 1: Implications for reovirus binding. Proc Natl Acad Sci USA 2003; 100:5366-5371.
30. Stehle T, Dermody TS. Structural similarities in the cellular receptors used by adenovirus and reovirus. Viral Immunol 2004; 17:129-143.
31. Forrest JC, Campbell JA, Schelling P et al. Structure-function analysis of reovirus binding to junctional adhesion molecule 1. Implications for the mechanism of reovirus attachment. J Biol Chem 2003; 278:48434-48444.
32. Kirchner E, Guglielmi KM, Strauss H et al. Structure of reovirus 1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog 2008; 4:e1000235.
33. Bewley MC, Springer K, Zhang YB et al. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999; 286:1579-1583.
34. van Raaij MJ, Chouin E, van der Zandt H et al. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. Structure 2000; 8:1147-1155.
35. Spear PG. Viral interactions with receptors in cell junctions and effects on junctional stability. Dev Cell 2002; 3:462-464.
36. Compton T. Receptors and immune sensors: The complex entry path of human cytomegalovirus. Trends Cell Biol 2004; 14:5-8.
37. Ugolini S, Mondor I, Sattentau QJ. HIV-1 attachment: Another look. Trends Microbiol 1999; 7:144-149.
38. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev lmmunol 1999; 17:657-700.
39. Barton ES, Connolly JL, Forrest JC et al. Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 2001; 276:2200-2211.
40. Maginnis MS, Forrest JC, Kopecky-Bromberg SA et al. γ1 integrin mediates internalization of mammalian reovirus. J Virol 2006; 80:2760-2770.
41. Breun LA, Broering TJ, McCutcheon AM et al. Mammalian reovirus L2 gene and 2 core spike protein sequences and whole-genome comparisons of reoviruses type 1 Lang, type 2 Jones, and type 3 Dearing. Virology 2001; 287:333-348.
42. Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25.
43. Hynes R. Integrins: Bidirectional, allosteric signaling machines. Cell 2002; 110:673-687.
44. Maginnis MS, Mainou BA, Derdowski AM et al. NPXY motifs in the γ1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol 2008; 82:3181-3191.
45. Sturzenbecker LJ, Nibert ML, Furlong DB et al. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol 1987; 61:2351-2361.
46. Borsa J, Morash BD, Sargent MD et al. Two modes of entry of reovirus particles into L cells. J Gen Virol 1979; 45:161-170.
47. Borsa J, Sargent MD, Lievaart PA et al. Reovirus: Evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 1981; 111:191-200.
48. Rubin DH, Weiner DB, Dworkin C et al. Receptor utilization by reovirus type 3: Distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions. Microb Pathog 1992; 12:351-365.
49. Ehrlich M, Boll W, Van Oijen A et al. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 2004; 118:591-605.
50. Georgi A, Mottola-Hartshorn C, Warner A et al. Detection of individual fluorescently labeled reovirions in living cells. Proc Natl Acad Sci USA 1990; 87:6579-6583.
51. Mainou BA, Dermody TS. Transport to late endosomes is required for efficient reovirus infection. J Virol 2012; 86:8346-8358.
52. Canning WM, Fields BN. Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science 1983; 219:987-988.
53. Maratos-Flier E, Goodman MJ, Murray AH et al. Ammonium inhibits processing and cytotoxicity of reovirus, a nonenveloped virus. J Clin Invest 1986; 78:617-625.
54. Maxfield FR. Weak bases and ionophores rapidly and reversibly raise the pH in endocytic vesicles in cultured mouse fibroblasts. J Cell Biol 1982; 95:676-681.
55. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978; 75:3327-3331.
56. Barrett AJ, Kembhavi AA, Brown MA et al. L-trans-Epoxysuccinyl- leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 1982; 201:189-198.
57. Baer GS, Dermody TS. Mutations in reovirus outer-capsid protein 3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol 1997; 71:4921-4928.
58. Chandran K, Nibert ML. Protease cleavage of reovirus capsid protein 1/1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle. J Virol 1998; 762:467-475.
59. Ebert DH, Wetzel JD, Brumbaugh DE et al. Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein 3. J Virol 2001; 75:3197-3206.
60. Jane-Valbuena J, Nibert ML, Spencer SM et al. Reovirus virion-like particles obtained by recoating infectious subvirion particles with baculovirus-expressed 3 protein: An approach for analyzing 3 functions during virus entry. J Virol 1999; 73:2963-2973.
61. Bond JS, Butler PE. Intracellular proteases. Annu Rev Biochem 1987; 56:333-364.
62. Gal S, Gottesman MM. The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity. Biochem Biophys Res Commun 1986; 139:156-162.
63. Gottesman MM, Sobel ME. Tumor promoters and Kirsten sarcoma virus increase synthesis of a secreted glycoprotein by regulating levels of translatable mRNA. Cell 1980; 19:449-455.
64. Kirschke H, Langner J, Wiederanders B et al. Cathepsin L. A new proteinase from rat-liver lysosomes. Eur J Biochem 1977; 74:293-301.
65. Ebert DH, Deussing J, Peters C et al. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002; 277:24609-24617.
66. Riese RJ, Wolf PR, Bromme D et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4:357-366.
67. Golden JW, Bahe JA, Lucas WT et al. Cathepsin S supports acid-independent infection by some reoviruses. J Biol Chem 2004; 279:8547-8557.
68. Johnson EM, Wetzel JD, Doyle JD et al. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J Virol 2009; 83:9630-9640.
69. Nygaard RM, Golden JW, Schiff LA. Impact of host proteases on reovirus infection in the respiratory tract. J Virol 2012; 86:1238-1243.
70. Tosteson MT, Nibert ML, Fields BN. Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses. Proc Natl Acad Sci USA 1993; 90:10549-10552.
71. Lucia-Jandris P, Hooper JW, Fields BN. Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol 1993; 67:5339-5345.
72. Hooper JW, Fields BN. Role of the 1 protein in reovirus stability and capacity to cause chromium release from host cells. J Virol 1996; 70:459-467.
73. Olland AM, Jane-Valbuena J, Schiff LA et al. Structure of the reovirus outer capsid and dsRNA-binding protein 3 at 1.8 A resolution. EMBO J 2001; 20:979-989.
74. Nason E, Wetzel J, Mukherjee S et al. A monoclonal antibody specific for reovirus outer-capsid protein 3 inhibits 1-mediated hemagglutination by steric hindrance. J Virol 2001; 75:6625-6634.
75. Wetzel JD, Wilson GJ, Baer GS et al. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J Virol 1997; 71:1362-1369.
76. Clark KM, Wetzel JD, Bayley J et al. Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein 3. J Virol 2006; 80:671-681.
77. Doyle JD, Danthi P, Kendall EA et al. Molecular determinants of proteolytic disassembly of the reovirus outer capsid. J Biol Chem 2012; 287:8029-8038.
78. Nibert ML, Schiff LA, Fields BN. Mammalian reoviruses contain a myristoylated structural protein. J Virol 1991; 65:1960-1967.
79. Smith RE, Zweerink HJ, Joklik WK. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 1969; 39:791-810.
80. Odegard AL, Chandran K, Zhang X et al. Putative autocleavage of outer capsid protein 1, allowing release of myristoylated peptide 1N during particle uncoating, is critical for cell entry by reovirus. J Virol 2004; 78:8732-8745.
81. Nibert ML, Odegard AL, Agosto MA et al. Putative autocleavage of reovirus 1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. J Mol Biol 2005; 345:461-474.
82. Bodkin DK, Nibert ML, Fields BN. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol 1989; 63:4676-4681.
83. Nibert ML, Fields BN. A carboxy-terminal fragment of protein 1/1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol 1992; 66:6408-6418.
84. Chandran K, Walker SB, Chen Y et al. In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins 1 and 3. J Virol 1999; 73:3941-3950.
85. Chandran K, Parker JS, Ehrlich M et al. The delta region of outer-capsid protein 1 undergoes conformational change and release from reovirus particles during cell entry. J Virol 2003; 77:13361-13375.
86. Ivanovic T, Agosto MA, Zhang L et al. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J 2008; 27:1289-1298.
87. Chandran K, Farsetta DL, Nibert ML. Strategy for nonenveloped virus entry: A hydrophobic conformer of the reovirus membrane penetration protein 1 mediates membrane disruption. J Virol 2002; 76:9920-9933.
88. Liemann S, Chandran K, Baker TS et al. Structure of the reovirus membrane-penetration protein, 1, in a complex with its protector protein, 3. Cell 2002; 108:283-295.
89. Tyler KL, Squier MK, Rodgers SE et al. Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein 1. J Virol 1995; 69:6972-6979.
90. Rodgers SE, Barton ES, Oberhaus SM et al. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol 1997; 71:2540-2546.
91. Connolly JL, Rodgers SE, Clarke P et al. Reovirus-induced apoptosis requires activation of transcription factor NF-κB. J Virol 2000; 74:2981-2989.
92. Oberhaus SM, Smith RL, Clayton GH et al. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol 1997; 71:2100-2106.
93. O'Donnell SM, Hansberger MW, Connolly JL et al. Organ-specific roles for transcription factor NF-κB in reovirus-induced apoptosis and disease. J Clin Invest 2005; 115:2341-2350.
94. DeBiasi R, Edelstein C, Sherry B et al. Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol 2001; 75:351-361.
95. DeBiasi RL, Robinson BA, Sherry B et al. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 2004; 78:11040-11050.
96. Connolly JL, Barton ES, Dermody TS. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 2001; 75:4029-4039.
97. Tyler KL, Squier MKT, Brown AL et al. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: Role of the S1 and M2 genes. J Virol 1996; 70:7984-7991.
98. Ernst H, Shatkin AJ. Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc Natl Acad Sci USA 1985; 82:48-52.
99. Jacobs BL, Atwater JA, Munemitsu SM et al. Biosynthesis of reovirus-specified polypeptides. The S1 mRNA synthesized in vivo is structurally and functionally indistinguishable from in vitro-synthesized S1 mRNA and encodes two polypeptides, 1a and 1bNS. Virology 1985; 147:9-18.
100. Sarkar G, Pelletier J, Bassel-Duby R et al. Identification of a new polypeptide coded by reovirus gene S1. J Virol 1985; 54:720-725.
101. Rodgers SE, Connolly JL, Chappell JD et al. Reovirus growth in cell culture does not require the full complement of viral proteins: Identification of a 1s-null mutant. J Virol 1998; 72:8597-8604.
102. Hoyt CC, Richardson-Burns SM, Goody RJ et al. Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol 2005; 79:2743-2753.
103. Boehme KW, Guglielmi KM, Dermody TS. Reovirus nonstructural protein 1s is required for establishment of viremia and systemic dissemination. Proc Natl Acad Sci USA 2009; 106:19986-19991.
104. Boehme KW, Frierson JM, Konopka JL et al. The reovirus 1s protein is a determinant of hematogenous but not neural viral dissemination in mice. J Virol 2011; 85:11781-11790.
105. Campbell JA, Shelling P, Wetzel JD et al. Junctional adhesion molecule-A serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 2005; 79:7967-7978.
106. Dermody TS, Nibert ML, Bassel-Duby R et al. A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol 1990; 64:5173-5176.
107. Connolly JL, Dermody TS. Virion disassembly is required for apoptosis induced by reovirus. J Virol 2002; 76:1632-1641.
108. Danthi P, Hansberger MW, Campbell JA et al. JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J Virol 2006; 80:1261-1270.
109. Hazelton PR, Coombs KM. The reovirus mutant tsA279 has temperature-sensitive lesions in the M2 and L2 genes: The M2 gene is associated with decreased viral protein production and blockade in transmembrane transport. Virology 1995; 207:46-58.
110. Danthi P, Kobayashi T, Holm GH et al. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J Virol 2008; 82:161-172.
111. Danthi P, Kobayashi T, Coffey CM et al. Independent regulation of reovirus membrane penetration and apoptosis by the 1 f domain. PLoS Pathog 2008; 4:e1000248.
112. Clarke P, Meintzer SM, Moffitt LA et al. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem 2003; 278:18092-18100.
113. Beg A, Finco T, Nantermet P et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IB: A mechanism for NF-κB activation. Mol Cell Biol 1993; 13:3301-3310.
114. Cahir McFarland ED, Izumi KM, Mosialos G. Epstein-barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene 1999; 18:6959-6964.
115. McKinsey TA, Brockman JA, Scherer DC et al. Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: A potential mechanism for constitutive induction of NF-kappaB. Mol Cell Biol 1996; 16:2083-2090.
116. Abbadie C, Kabrun N, Bouali F et al. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 1993; 75:899-912.
117. Grimm S, Bauer MKA, Baeuerle PA et al. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 1996; 134:13-23.
118. Jung M, Zhang Y, Lee S et al. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IB-. Science 1995; 268:1619-1621.
119. Beg A, Baltimore D. An essential role for NF-κB in preventing TNF-κ-induced cell death. Science 1996; 274:782-784.
120. Liu ZG, Hsu H, Goeddel D et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87:565-576.
121. Van Antwerp D, Martin S, Kafri T et al. Suppression of TNF-κ-induced apoptosis by NF-κB. Science 1996; 274:787-789.
122. Clarke P, Meintzer SM, Widmann C et al. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J Virol 2001; 75:11275-11283.
123. Clarke P, Meintzer SM, Wang Y et al. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol 2004; 78:13132-13138.
124. Norman KL, Hirasawa K, Yang AD et al. Reovirus oncolysis: The Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci USA 2004; 101:11099-11104.
125. Meusel TR, Imani F. Viral induction of inflammatory cytokines in human epithelial cells follows a p38 mitogen-activated protein kinase-dependent but NF-kappa B-independent pathway. J Immunol 2003; 171:3768-3774.
126. Duncan MR, Stanish SM, Cox DC. Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol 1978; 28:444-449.
127. Strong JE, Coffey MC, Tang D et al. The molecular basis of viral oncolysis: Usurpation of the Ras signaling pathway by reovirus. EMBO J 1998; 17:3351-3362.
128. Strong JE, Lee PW. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J Virol 1996; 70:612-616.
129. Coffey MC, Strong JE, Forsyth PA et al. Reovirus therapy of tumors with activated Ras pathway. Science 1998; 282:1332-1334.
130. Mundschau LJ, Faller DV. Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation. J Biol Chem 1992; 267:23092-23098.
131. Williams ME, Cox DC, Stevenson Jr. Rejection of reovirus-treated L1210 leukemia cells by mice. Cancer Immunol Immunother 1986; 23:87-92.
132. Wilcox ME, Yang W, Senger D et al. Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst 2001; 93:903-912.
133. Norman KL, Coffey MC, Hirasawa K et al. Reovirus oncolysis of human breast cancer. Hum Gene Ther 2002; 13:641-652.
134. Holm GH, Zurney J, Tumilasci V et al. Retinoic acid-inducible gene-I and interferon-γ promoter stimulator-1 augment proapoptotic responses following mammalian reovirus infection via interferon regulatory factor-3. J Biol Chem 2007; 282:21953-21961.
135. Kato H, Takeuchi O, Mikamo-Satoh E et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008; 205:1601-1610
136. Loo YM, Fornek J, Crochet N et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008; 82:335-345.
137. Knowlton JJ, Dermody TS, Holm GH. Apoptosis induced by mammalian reovirus is interferon-γ-independent and enhanced by IRF-3- and NF-κB-dependent expression of Noxa. J. Virol 2012; 86:1650-1660.
138. DeBiasi RL, Clarke P, Meintzer SM et al. Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol 2003; 77:8934-8947.
139. O'Donnell SM, Holm GH, Pierce JM et al. Identification of an NF-κB-dependent gene network in cells infected by mammalian reovirus. J Virol 2006; 80:1077-1086.
140. Smith JA, Schmechel SC, Raghavan A et al. Reovirus induces and benefits from an integrated cellular stress response. J Virol 2006; 80:2019-2033.
141. Webster GA, Perkins ND. Transcriptional cross talk between NF-κ B and p53. Mol Cell Biol 1999; 19:3485-3495.
142. Dreyfus D, Nagasawa M, Gelfand E et al. Modulation of p53 activity by IB: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors. BMC Immunol 2005; 6:12.
143. Li Z, Niu J, Uwagawa T et al. Function of polo-like kinase 3 in NF-κB-mediated proapoptotic response. J Biol Chem 2005; 280:16843-16850.
144. Huang YH, Wu JY, Zhang Y et al. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Oncogene 2002; 21:6819-6828.
145. Liu CY, Schröder M, Kaufman RJ. Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum. J Biol Chem 2000; 275:24881-24885.
146. Harding HP, Zhang Y, Bertolotti A et al. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5:897-904.
147. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55:255-281.
148. Stark GR, Kerr IM, Williams BR et al. How cells respond to interferons. Annu Rev Biochem 1998; 67:227-264.
149. Kunzi MS, Pitha PM. Interferon targeted genes in host defense. Autoimmunity 2003; 36:457-461.
150. Tanaka N, Sato M, Lamphier MS et al. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 1998; 3:29-37.
151. Bingle CD, Craig RW, Swales BM et al. Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem 2000; 275:22136-22146.
152. Gurumurthy S, Goswami A, Vasudevan KM et al. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol Cell Biol 2005; 25:1146-1161.
153. Imazu T, Shimizu S, Tagami S et al. Bcl-2/E1B 19 kDa-interacting protein 3-like protein (Bnip3L) interacts with Bcl-2/Bcl-xL and induces apoptosis by altering mitochondrial membrane permeability. Oncogene 1999; 18:4523-4529.
154. Tan KO, Tan KML, Chan SL et al. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with bax through its Bcl-2 homology domains. J Biol Chem 2001; 276:2802-2807.
155. Clarke P, Meintzer SM, Gibson S et al. Reovirus-induced apoptosis is mediated by TRAIL. J Virol 2000; 74:8135-8139.
156. Torii S, Egan DA, Evans RA et al. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 1999; 18:6037-6049.
157. Takahashi Y, Lallemand-Breitenbach V, Zhu J et al. PML nuclear bodies and apoptosis. Oncogene 2004; 23:2819-2824.
158. Richardson-Burns SM, Kominsky DJ, Tyler KL. Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol 2002; 8:365-380.
159. Blatt NB, Glick GD. Signaling pathways and effector mechanisms preprogrammed cell death. Bioorg Med Chem 2001; 9:1371-1384.
160. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ 2002; 9:926-933.
161. Wajant H, Johannes FJ, Haas E et al. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol 1998; 8:113-116.
162. Clarke P, Debiasi RL, Meintzer SM et al. Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis 2005; 10:513-524.
163. Chawla-Sarkar M, Lindner DJ, Liu YF et al. Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003; 8:237-249.
164. Shigeno M, Nakao K, Ichikawa T et al. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 2003; 22:1653-1662.
165. Li P, Nijhawan D, Budhardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489.
166. Verhagen AM, Ekert PG, Pakusch M et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102:43-53.
167. Du C, Fang M, Li Y et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102:33-42.
168. Joza N, Susin SA, Daugas E et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410:549-554.
169. Li H, Zhu H, Xu CJ et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491-501.
170. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol 2002; 76:11414-11424.
171. Danthi P, Pruijssers AJ, Berger AK et al. Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog 2010; 6:e1000980.
172. Luo X, Budihardjo I, Zou H et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94:481-490.
173. Richardson-Burns SM, Tyler KL. Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol 2004; 78:5466-5475.
174. Richardson-Burns SM, Tyler KL. Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol 2005; 192:331-339.
175. Sherry B, Torres J, Blum MA. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol 1998; 72:1314-1323.
176. Azzam-Smoak K, Noah DL, Stewart MJ et al. Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology 2002; 298:20-29.
177. Stewart MJ, Blum MA, Sherry B. PKR's protective role in viral myocarditis. Virology 2003; 314:92-100.
178. Noah DL, Blum MA, Sherry B. Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J Virol 1999; 73:10208-10213.
179. Bazzoni G, Martinez-Estrada OM, Orsenigo F et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000; 275:20520-20526.
180. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 2000; 275:27979-27988.
181. Pfaff M, Liu S, Erle DJ et al. Integrin beta cytoplasmic domains differentially bind to cytoskeletal proteins. J Biol Chem 1998; 273:6104-6109.
182. Otey CA, Pavalko FM, Burridge K. An interaction between alpha-actinin and the beta 1 integrin subunit in vitro. J Cell Biol 1990; 111:721-729.
183. Schaller MD, Otey CA, Hildebrand JD et al. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 1995; 130:1181-1187.
184. Reszka AA, Hayashi Y, Horwitz AF. Identification of amino acid sequences in the integrin beta 1 cytoplasmic domain implicated in cytoskeletal
185. Chen WJ, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem 1990; 265:3116-3123.
186. Deiss LP, Galinka H, Berissi H et al. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996; 15:3861-3870.
187. Guicciardi ME, Deussing J, Miyoshi H et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106:1127-1137.
188. Roberg K. Relocalization of cathepsin D and cytochrome c early in apoptosis revealed by immunoelectron microscopy. Lab Invest 2001; 81:149-158.
189. Stoka V, Turk B, Schendel SL et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001; 276:3149-3157.
190. Coffey CM, Sheh A, Kim IS et al. Reovirus outer capsid protein 1 induces apoptosis and associates with lipid droplets, endoplasmic reticulum, and mitochondria. J. Virol. 80:8422-38, 2006.
191. Kim JW, Lyi SM, Parrish CR, Parker JS. A proapoptotic peptide derived from reovirus outer capsid protein 1 has membrane-destabilizing activity. J Virol 2011; 85:1507-16.
192. Wisniewski ML, Werner BG, Hom LG et al. Reovirus infection or ectopic expression of outer capsid protein 1 induces apoptosis independently of the cellular proapoptotic proteins Bax and Bak. J Virol 2011; 85:296-304.